1 INVENTIONS · 2018. 7. 5. · There is disclosed an information processing device that displays a link related to one peripheral device on a device screen. The information processing

Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines

Tel. No. 238-6300 Website: http://www.ipophil.gov.ph e-mail: [email protected] Volume 21 Number 72

Date Released: July 06, 2018

Invention Granted Under R.A. 8293 (PCT)

1 INVENTIONS

[19] INTELLECTUAL PROPERTY PHILIPPINES

[12] INVENTION GRANT

[21] Registration Number: 1/2008/502681 Document Code: B1

[45] Issue Date: 21 March 2018

[22] Date Filed: 5 December 2008

[54] Title: FABRIC SOFTENER COMPOSITION

[71] Proprietors(s): UNILEVER NV [NL]

[72] Inventor(s): MCFARLAND, Kathryn[ZA]: SABBAGH, Liezel[ZA]

[73] Assignee(s): UNILEVER NV [NL]

[74] Attorney / Agent: OSCAR M. MANAHAN, ESQ.

[30] Priority Data: 0611486.2 09/06/2006 GB

[51] International Class 8: C11D 1/62; C11D 17/00; C11D 3/04; C11D 3/26; C11D 3/37

[57] Abstract:

A stable, concentrated (pre-dilute) aqueous fabric softening composition having a viscosity of from 300 to 1000, preferably 300 to 850, more preferably 400 to 800 mPa.s at 116 s-1 which composition is capable of being diluted with water in a 3:1 weight ratio of water:softening composition such that the resulting diluted softening composition is physically stable and has a viscosity of from 40 to 100 mPa.s at 116 s-1, preferable 50 to 90 mPa.s at 116 s-1 the composition comprising a) a cationic fabric softener b) 0.7 to 2.5 % by weight of a cationic cross-linked polymer that is desirable from the polymerization of from 5 to 100 mole percent of cationic vinyl addition monomer, from 0 to 95 mole percent of acrylamide and from 50 to 1000 ppm, preferably 350 to 1000 ppm, more preferably 500 to 1000 ppm of a difunctional vinyl addition monomer cross-linking agent, c) from 0.001 to 0.2 by weight of electrolyte.

Representative Drawing(s): NONE

[56] Reference(s) Cited and/or Considered:

Document description

WO 2004/061066A (Colgate Palmolive Co [US]), 22 July 2004

US 2004/116321A1 (Salesses Isabelle [BE] et. al), 17 June 2004

No. of Claims: 16








[22] Date Filed: 14 October 2009

[54] Title: RUMC PEPTIDES WITH ANTIMICROBIAL ACTIVITY

[71] Proprietors(s): ADISSEO FRANCE S.A.S. [FR]

[72] Inventor(s): FONS, Michel[FR]: CROST, Emmanuelle[FR]: GERAERT, Pierre-Andre[FR]

[73] Assignee(s): ADISSEO FRANCE S.A.S. [FR]

[74] Attorney / Agent: ATTY. AUGUSTO Y ARREZA, JR.

[30] Priority Data: 0703789 29/05/2007 FR

[51] International Class 8: C07K 14/195; C07K 7/04; C07K 7/06; C12N 15/31

[57] Abstract: The present invention relates to the RumC1, RumC2 and RumC3 peptides with antimicrobial activity, and also to the genes encoding these peptides and isolated from Ruminococcus gnavus E1.

Representative Drawing(s):



DABARD J ET AL.: “ Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces” APPLIED AND ENVIRONMENTAL MICROBIOLOGY

GOMEZ ANA ET AL.: “Tryp mediates growth phase- dependent transcriptional regulation of genes involved in biosynthesis of ruminococcin A, a lantibiotic produced by a Ruminococcus gnavus strain from human intestinal microbiota”

No. of Claims: 33








[22] Date Filed: 4 April 2012

[54] Title: INFORMATION PROCESSING DEVICE THAT COMMUNICATES WITH PERIPHERAL DEVICE, METHOD, AND CONTROL PROGRAM

[71] Proprietors(s): CANON KABUSHIKI KAISHA [JP]

[72] Inventor(s): ARITOMI, Masanori[JP]

[73] Assignee(s): CANON KABUSHIKI KAISHA [JP]

[74] Attorney / Agent: SALUDO FERNANDEZ AND AQUINO (SAFA LAW)

[30] Priority Data: NONE

[51] International Class 8: G06F 13/00

[57] Abstract:

There is disclosed an information processing device that displays a link related to one peripheral device on a device screen. The information processing device includes obtaining means for obtaining device information of a peripheral device, link forming means for forming the link corresponding to setting information obtained by the obtaining means, and access means for accessing a device management program that manages the peripheral device corresponding to the link when it is determined that an instruction of the link formed by the link forming means has been provided on the device screen.




JP 2008 287671 A NIPPON TELEGRAPH AND TELEPHONE 27 November 2008 (27.11.2008)

JP 2008 077357 A FUJI XEROX CO LTD. 03 April 2008 (03.04.2008)




JP 2004 038526 A BROTHER IND LTD. 05 February 2004 (05.02.2004)

No. of Claims: 11








[22] Date Filed: 22 June 2012

[54] Title: POLYAMIDE RESIN-TYPE COMPOSITE MATERIAL AND METHOD OF PRODUCING SAME

[71] Proprietors(s): MITSUBISHI GAS CHEMICAL COMPANY, INC. [JP]

[72] Inventor(s): MITADERA Jun [JP]

[73] Assignee(s): MITSUBISHI GAS CHEMICAL COMPANY, INC. [JP]

[74] Attorney / Agent: SANTOS PILAPIL & ASSOCIATES

[30] Priority Data: 2011-087830 12/04/2011 JP

[51] International Class 8: C08J 5/04; C08K 7/02; C08L 77/10

[57] Abstract:

A xylylenediamine-based polyamide resin/fiber composite material and molding are provided that do not exhibit a decline in properties under high temperatures and high humidities, and that exhibit a high elastic modulus and present little warping, and exhibit better recycle characteristics, a better moldability, and a better productivity than for thermosetting resins. The polyamide resin-type composite material comprises a fibrous material (B) impregnated with a polyamide resin (A) wherein at least 50 mole% of diamine structural units derived from xylylenediamine, and having a number-average molecular weight (Mn) of 6,000 to 30,000, and containing a component of a molecular weight of not more than 1,000 at 0.5 to 5 mass %.




JP 2007-269914A (Asahi Kasei Chemicals Corp,), 18 October 2007

JP 2002-322272A ( Toray Industries, Inc.), 08 November 2002

JP 63-82731A (Societe Atochem), 13 April 1988

No. of Claims: 30








[22] Date Filed: 6 September 2012

[54] Title: CONTROLLED RELEASE MENTHOLATED TOBACCO BEADS

[71] Proprietors(s): PHILIP MORRIS PRODUCTS S.A. [CH]

[72] Inventor(s): KARLES, Georgios D.[US]: ZHUANG, Shuzhong[US]: ZENG, Yi[US]

[73] Assignee(s): PHILIP MORRIS PRODUCTS S.A. [CH]

[74] Attorney / Agent: SIGUION REYNA MONTECILLO & ONGSIAKO LAW OFFICES

[30] Priority Data: 12/748, 259 26/03/2010 US

[51] International Class 8: A24B 15/28

[57] Abstract:

Encapsulated tobacco beads and processes of making the encapsulated tobacco beads are disclosed. According to an embodiment, a process of making encapsulated tobacco beads comprises mixing tobacco particles and menthol in an aqueous solution to form a wet mass; extruding the wet mass to form extrudates; spheronizing the extrudates to form tobacco beads; drying the tobacco beads; contacting the beads with a solution comprising a cation; and introducing the contacted tobacco beads into a solution of coating material in a concentration effective to induce ionic gelation of the coating material around the beads, to form encapsulated tobacco beads having gel coatings. According to another embodiment, an encapsulated tobacco bead comprises a core comprising tobacco particles and encapsulated menthol, an inner coating layer comprising hydroxypropyl methylcellulose or pectin, and an outer coating layer comprising an ionically-crosslinked gel.







WO 2006/090290 A1( PHILIP MORRIS PROD) 31 August 2006

WO 2008/059375 A2 ( PHILIP MORRIS PROD) 22 May 2008

No. of Claims: 12








[22] Date Filed: 20 November 2012

[54] Title: A NIGHT VISION DEVICE.

[71] Proprietors(s): ASELSAN ELEKTRONIK SANAYI VE TICARET ANONIM SIRKETI [TR]

[72] Inventor(s): OZSOY, Ihsan[TR]: ANIL, Devrim[TR]: GENCOGLU, Selim[TR]

[73] Assignee(s): ASELSAN ELEKTRONIK SANAYI VE TICARET ANONIM SIRKETI [TR]

[74] Attorney / Agent: HECHANOVA & CO., INC.

[30] Priority Data: TR 2010/03109 20/04/2010 TR

[51] International Class 8: G02B 13/14; G02B 23/00; G02B 23/12; G02B 7/02; G02B 7/04

[57] Abstract:

The present invention relates to a night vision device (1) which enables the user to see under conditions where there is low light by intensifying the light in the environment, is portable and easy to use. The inventive device (1) can be mounted to head, helmet or weapon; it is also hand-held. The inventive night vision device (1) comprises an objective assembly (2) which focus the light in the environment; an intensifier tube (3) which enables the user to see the environment by intensifying the light that is focused by the objective assembly (2); a lower body (4) which prevents the intensifier tube (3) from external factors by surrounding it; an upper body (5) which is fixed to the lower body (4); an ocular assembly (6) which focuses the light that is provided from the intensifier tube (3) to the user's eye; an eyecup (8) which enables the light that is provided from the ocular assembly (6) by surrounding the user's eye to reach the user; and an electronic card (13).







US 5,604,630 - GARY L. PALMER - 18 February 1997

US 5,644,425 A - GARY L. PALMER - 1 July 1997

No. of Claims: 16








[22] Date Filed: 8 February 2013

[54] Title: SYSTEM AND METHOD FOR GENERATING ELECTRICAL POWER FROM A FLOWING CURRENT OF FLUID

[71] Proprietors(s): JUPITER HYDRO INC. [CA]

[72] Inventor(s): SINCLAIRE, Ross[CA]

[73] Assignee(s): JUPITER HYDRO INC. [CA]

[74] Attorney / Agent: FOLLOSCO MORALLOS & HERCE

[30] Priority Data: 61/372,775 11/08/2010 US and 61/385,362 22/09/2010 US

[51] International Class 8: E02B 9/08; F03B 13/12; F03B 13/22; F03B 17/06

[57] Abstract:

A helical turbine is operatively connected to at least one generator system for generating electrical power. System performance is optimized by controlling the operative angle between the longitudinal axis of the turbine and the direction of the current flow and by controlling a pitch ratio of the turbine. A pair of turbines, arranged in V-shape, each at the operative angle from a neutral centerline, provides symmetry and counteracts reactive torque. For wind operations, the V- shape is freely rotatable into the wind. For bi-directional tidal operations, the V- shape is part of a buoyant structure, positioned in the current and anchored to the floor. The structure is fit with control surfaces to ensure the system orientation. In unidirectional currents, one or more turbines can be angled downwardly into the current at the operative angle, elevators ensuring the angle is maintained.




FR2505937 A1 Dementhon November 19, 1982

WO2006/059094 A1 Bowie June 8, 2006

GB108632 A Bertoncini August 16, 1917

US3187816 A Winter June 8, 1965

EP2003332 A1 Wolff December 17, 2008

No. of Claims: 24








[22] Date Filed: 20 February 2013

[54] Title: ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3)

[71] Proprietors(s): NOVARTIS AG [CH]

[72] Inventor(s): ELIS, Winfried[DE]: ETTENBERG, Seth[US]: GARNER, Andrew Paul[GB]: HAUBST, Nicole[DE]: KUNZ, Christian Carsten Silvester[DE]: REISINGER SPRAGUE, Elizabeth Anne[US]

[73] Assignee(s): NOVARTIS AG [CH]

[74] Attorney / Agent: SYCIP SALAZAR HERNANDEZ & GATMAITAN

[30] Priority Data: 61/375,408 20/08/2010 US

[51] International Class 8: A61K 39/395; A61P 35/00; C07K 16/32

[57] Abstract:

The present invention relates to antibodies or fragments thereof that target a conformational epitope of a HER receptor. In particular, the invention relates to antibodies or fragments thereof that target a conformational epitope of HER3 receptor and compositions and methods of use thereof.




WO 2007/077028 A2 (U3 PHARMA AG, ET AL.) 12 July 2007.

WO 2006/087637 A2 (HELLENIC PASTEUR INST., ET AL.) 24 August 2006.

WO 2008/019290 A2 (ASTRAZENECA AB, ET AL.) 14 February 2008.

FRANKLIN M C ET AL.: "Insights into ErbB signaling from the structure of the..." CANCER CELL, CELL PRESS, US, vol. 5, no. 4, 01 April 2004, pp. 317-328, XP002372929, ISSN: 1535-6108.

CHO HYUN_SOO ET AL.: "Structure of the extracellular region of HER3 reveals an interdomaintether", SCIENCE (WASHINGTON DC), vol. 297, no. 5585, 23 August 2002, pp. 1330-1333,




XP002662196, ISSN: 0036-8075.

BURGESS A W ET AL: "An open-and-shut case? Recent insights into the activation...." MOLECULAR CELL, CELL PRESS, CAMBRIDGE, MA, US, vol. 12, no. 3, 1 September 2003, pp. 541-552, XP002396190, ISSN: 1097-2765.

No. of Claims: 37








[22] Date Filed: 5 March 2013

[54] Title:

AGENT FOR TREATMENT OF DRY EYE CHARACTERIZED BY COMBINING P2Y2 RECEPTOR AGONIST AND HYALURONIC ACID OR SALT THEREOF, METHOD FOR TREATING DRY EYE, AND USE OF THE P2Y2 RECEPTOR AGONIST AND HYALURONIC ACID OR SALT THEREOF

[71] Proprietors(s): SANTEN PHARMACEUTICAL CO., LTD. [JP]

[72] Inventor(s): SHICHIJO, Yuko[JP]: DOTA, Atsuyosh[JP]: NAGANO Takashi[JP]: NAKAMURA Masatsugu[JP]: SAKAMOTO Asuka[JP]

[73] Assignee(s): SANTEN PHARMACEUTICAL CO., LTD. [JP]

[74] Attorney / Agent: SIGUION REYNA MONTECILLO & ONGSIAKO LAW OFFICES

[30] Priority Data: 2010-203198 10/09/2010 JP

[51] International Class 8: A61K 31/675; A61K 31/728; A61K 45/00; A61P 27/02

[57] Abstract:

Disclosed is an agent for the treatment of dry eye, which is characterized by combining a P2Y2 receptor agonist at a therapeutically effective concentration with hyaluronic acid or a salt thereof at a therapeutically effective concentration. This agent for the treatment of dry eye, which is in the form of an ophthalmic agent, remarkably promotes tear secretion and remarkably improves corneal epithelial disorder, and is thus expected to be a novel agent for the treatment of dry eye.




US 2005/0085439 A1 (Yerxa et al.) 4/2005

US 2008/0009463 A1 (Yerxa et al.) 1/2008

No. of Claims: 6









[54] Title: LIQUID HEATER WITH TEMPERATURE CONTROL

[71] Proprietors(s): Heatworks Technologies, Inc. [US]

[72] Inventor(s): BOWERS, John, H.[US]: LYON, Gregory, S.[US]

[73] Assignee(s): Heatworks Technologies, Inc. [US]

[74] Attorney / Agent: ANGARA ABELLO CONCEPCION REGALA & CRUZ


[51] International Class 8: F24H 1/10; F24H 9/00; F24H 9/14; F24H 9/20; G01K 13/02; G01K 7/16

[57] Abstract:

A liquid heater such as a direct electrical resistance liquid heater having multiple flow channels (48, 52) is provided with a temperature-sensing element in the form of a wire (76) extending across numerous channels, preferably all of the channels, near the downstream ends of the channels. The resistance of the wire represents the average temperature of the liquid passing through all of the channels, and hence the temperature of the mixed liquid exiting from the heater. A bubble suppressing structure (54) is provided in the vicinity of the wire.




WO2005/020175 A1 Boeing Co. March 3, 2005

US5167153 A McQueen Malcolm December 1, 1992

US2006/291527 A1 Callahan Jeremiah December 28, 2006

No. of Claims: 6









[54] Title: O-PHOSPHOSERINE SULFHYDRYLASE MUTANTS AND METHOD FOR PRODUCTION OF CYSTEINE USING THE SAME

[71] Proprietors(s): CJ CHEILJEDANG CORPORATION [KP]

[72] Inventor(s): SHIN, Soo An[KR]: CHANG, Jin Sook[KR]: UM, Hye Won[KR]: JO, Jae Hyun[KR]: SONG, Byeong Cheol [KR]: LEE, Kyoung Min[KR]

[73] Assignee(s): CJ CHEILJEDANG CORPORATION [KP]

[74] Attorney / Agent: HECHANOVA & CO., INC.

[30] Priority Data: 10-2010-0102665 20/10/2010 KR

[51] International Class 8: C12N 15/54; C12N 9/10; C12P 13/12

[57] Abstract:

Disclosed is an O-phosphoserine sulfhydrylase (OPSS) mutant which has a Mycobacterium smegmatis-derived amino acid sequence corresponding to that of SEQ ID NO: 1 which is devoid of three to seven C-terminal amino acid residues. Also, a nucleic acid molecule encoding the OPSS mutant, an expression vector carrying the nucleic acid molecule, and a transformant transformed with the expression vector are disclosed. In addition, a method is provided for producing cysteine in which O-phospho-L-serine (OPS) is reacted with a sulfide in the presence of the OPSS mutant. The OPSS mutant has improved enzymatic activity and can be applied to the environmentally friendly production of L-cysteine through a simple enzymatic conversion reaction.



NONE

No. of Claims: 64









[54] Title: IMPROVED SEALING COMPOSITION

[71] Proprietors(s): TRYDEL RESEARCH PTY LTD [AU]

[72] Inventor(s): DOWEL, Terence[AU]

[73] Assignee(s): TRYDEL RESEARCH PTY LTD [AU]

[74] Attorney / Agent: MANUEL C. CASES, JR. AND ASSOCIATES

[30] Priority Data: 2007905526 09/10/2007 AU; 2007905745 19/10/2007 AU and 2007906682 07/12/2007 AU

[51] International Class 8: B29C 73/16; C09K 3/10; C09K 3/12

[57] Abstract: A sealant composition for the sealing of a punctured tyre including a liquid carrier, one or more viscosity and suspending agents, one or more fillers and sealants, and one or more polyacrylates.




WO 1996/005048 A1 (DOWEL, TERENCE) 22 February 1996

WO 2006/038824 A1 (TIGAU, VALENTINA) 13 April 2006

US 4,588,758 A (JASPON) 13 May 1986

us 2, 827,098 A (SEMEGEN ET AL) 18 March 1958

No. of Claims: 6








[22] Date Filed: 23 May 2013

[54] Title: METHOD FOR AUTOMATIC CONTROL AND POSITIONING OF AUTONOMOUS DOWNHOLE TOOLS

[71] Proprietors(s): EXXONMOBIL UPSTREAM RESEARCH COMPANY [US]

[72] Inventor(s): KUMARAN, Krishnan[US]: SUBRAHMANYA, Niranjan, A.[IN]: ENTCHEV, Pavlin, B.[US]: TOLMAN, Randy, C.[US]: ANGELES BOZA, Renzo, M.[PE]

[73] Assignee(s): EXXONMOBIL UPSTREAM RESEARCH COMPANY [US]

[74] Attorney / Agent: BUCOY POBLADOR & ASSOCIATES

[30] Priority Data: 61/424,285 17/12/2010 US

[51] International Class 8: E21B 47/00

[57] Abstract:

Methods and apparatus for actuating a downhole tool in wellbore includes acquiring a CCL data set or log from the wellbore that correlates recorded magnetic signals with measured depth, and selects a location within the wellbore for actuation of a wellbore device. The CCL log is then downloaded into an autonomous tool. The tool is programmed to sense collars as a function of time, thereby providing a second CCL log. The autonomous tool also matches sensed collars with physical signature from the first CCL log and then self-actuates the wellbore device at the selected location based upon a correlation of the first and second CCL logs.







US 2005/0241835 A1, BURRIS II, Wesley J., et al, 03 November 2005

US 5,705,812 A, BREWER, James E., et al, 06 January 1998

US 2013/0062055 A1, TOLMAN, Randy C., et al, 14 March 2013

US 3,396,786 A, SCHUSTER, Nick A., et al, 13 August 1968

No. of Claims: 33









[54] Title: INDENO-FUSED RING COMPOUNDS

[71] Proprietors(s): TRANSITIONS OPTICAL, INC. [US]

[72] Inventor(s): HE, Meng[US]: KUMAR, Anil[US]: DABIDEEN, Darrin R.[US]

[73] Assignee(s): TRANSITIONS OPTICAL, INC. [US]

[74] Attorney / Agent: HECHANOVA AND CO., INC.

[30] Priority Data: 13/222,457 31/08/2011 US

[51] International Class 8: C07D 311/92; C07D 311/94; C09K 9/02; G02B 1/04; G02B 5/30

[57] Abstract:

The present invention relates to compounds represented by the following Formulas (I) and (II),

Ring-A of Formulas I and II can be, for example, an aryl group, and Q' and Q''' can each be independently selected from groups, such as, halogen, -OH, -CN, amine groups, amide groups, carboxylic acid ester groups, carboxylic acid groups, alkenyl groups, alkynyl groups, carbonate groups, sulfide groups, and sulfonic acid ester groups. The present invention also relates to photochromic compositions and photochromic articles that include one or more photochromic compounds, such as represented by Formula II.







US2011140056 (HE MENG, et al) 16 June 2011


WO0119813 (TRANSITIONS OPTICAL INC) 22 March 2001

US2005004361 (KUMAR ANIL, et al) 06 January 2005


No. of Claims: 21









[54] Title: METHODS OF USING HUMAN MILK OLIGOSACCHARIDES FOR IMPROVING AIRWAY RESPIRATORY HEALTH

[71] Proprietors(s): ABBOTT LABORATORIES [US]

[72] Inventor(s): BUCK, Rachael[US]: DUSKA-MCEWEN, Geralyn O.[US]: DAVIS, Steven R.[US]

[73] Assignee(s): ABBOTT LABORATORIES [US]

[74] Attorney / Agent: HECHANOVA AND CO., INC.

[30] Priority Data: 61/527,851 26/08/2011 US

[51] International Class 8: A61K 31/7016; A61K 31/702; A61P 11/00

[57] Abstract: Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to preterm infants, term infants, toddlers, and children for improving airway defense mechanisms.



NONE

No. of Claims: 24









[54] Title: ANTISKINNING COMPOSITIONS

[71] Proprietors(s): OMG UK TECHNOLOGY LIMITED [GB]

[72] Inventor(s): HAGE, Ronald[NL]: GOL, Franjo[DE]: GIBBS, Hugh Wynn[GB]: MAAIJEN, Karin[NL]

[73] Assignee(s): OMG UK TECHNOLOGY LIMITED [GB]

[74] Attorney / Agent: OSCAR M. MANAHAN, ESQ

[30] Priority Data: 11250005.3 06/01/2011 EP

[51] International Class 8: C09D 167/08; C09D 7/04

[57] Abstract:

The present invention relates to paint, ink and other coating formulations, particularly alkyd-based formulations comprising metal driers, such as iron- and manganese-containing compounds, which exhibit a reduced propensity to develop a skin on storage.




WO 2008/003652 (Unilever PLC, et al) 10 January 2008

WO 2007/024592 (Arkema Inc.) 1 March 2007

WO 2007/024592 (Arkema Inc.) 1 March 2007

No. of Claims: 18








[22] Date Filed: 30 July 2013

[54] Title: COMPOSITIONS FOR CANINE RESPIRATORY DISEASE COMPLEX

[71] Proprietors(s): ZOETIS SERVICES LLC [US]

[72] Inventor(s): ABDELMAGID, Omar, Yousif[SD]: BRICKER, Joseph, Michael[US]: SHIELDS, Shelly, Lynn[US]

[73] Assignee(s): ZOETIS SERVICES LLC [US]

[74] Attorney / Agent: E.B. ASTUDILLO AND ASSOCIATES


[51] International Class 8: A61K 39/10; A61K 39/145; A61K 39/215

[57] Abstract:

Provided herein are compositions comprising a canine influenza virus and a canine respiratory coronavirus. They can further comprise Bordetella bronchiseptica, pertactin, canine parainfluenza virus, and canine adenovirus serotype 2. The compositions are effective for treating or preventing canine respiratory diseases, including canine infectious respiratory disease complex.




US 2004/0185602 A1 (Chaudhuri et al.) 9/2004

US 2007/0082012 A1 (Shields et al.) 4/2007

No. of Claims: 12








[22] Date Filed: 15 August 2013

[54] Title: C-4" POSITION SUBSTITUTED MACROLIDE DERIVATIVE

[71] Proprietors(s): TAISHO PHARMACEUTICAL CO., LTD. [JP] and MEIJI SEIKA PHARMA CO., LTD. [JP]

[72] Inventor(s):

SUGIMOTO, Tomohiro[JP]: SASAMOTO, Naoki[JP]: KUROSAKA, Jun[JP]: HAYASHI, Masato[JP]: YAMAMOTO, Kanako[JP]: KASHIMURA, Masato[JP]: USHIKI, Yasunobu[JP]: OGITA, Haruhisa[JP]: MIURA, Tomoaki[JP]: KANEMOTO, Kenichi[JP]: KUMURA, Kou[JP]: YOSHIDA, Satoshi[JP]: TAMURA, Keiji[JP]: SHITARA, Eiki[JP]

[73] Assignee(s): TAISHO PHARMACEUTICAL CO., LTD. [JP] and MEIJI SEIKA PHARMA CO., LTD. [JP]

[74] Attorney / Agent: SANTOS PILAPIL AND ASSOCIATES

[30] Priority Data: 2011-034578 21/02/2011 JP

[51] International Class 8: A61K 31/7048; A61P 31/04; C07H 17/08

[57] Abstract:

A macrolide compound represented by the formula (I) effective against erythromycin resistant bacteria (for example, resistant pneumococci, streptococci and mycoplasmas).



NONE

No. of Claims: 26









[54] Title: METHODS FOR HANDLING BIOLOGICAL DRUGS CONTAINING LIVING CELLS

[71] Proprietors(s): IMMUNOVATIVE THERAPIES, LTD. [IL]

[72] Inventor(s): HAR-NOY, Michael[US]

[73] Assignee(s): IMMUNOVATIVE THERAPIES, LTD. [IL]

[74] Attorney / Agent: CRUZ MARCELO AND TENEFRANCIA

[30] Priority Data: 61/481,991 03/05/2011 US; 61/528,493 29/08/2011 US; 61/565,225 30/11/2011 US and 61/582,878 04/01/2012 US

[51] International Class 8: A61K 35/17; A61K 39/00; G01N 33/53

[57] Abstract:

The present invention includes methods for handling live cell compositions in non- nutritive buffer. The cells in the compositions maintain their identity and functional characteristics after being stored in non-nutrititive media up to about 72 hours. The storage method enables the cells to be manufactured at a processing facility and shipped to a point of care site. The invention also includes compositions that have been stored in non-nutritive buffer at storage temperatures while maintaining the functional characteristics.




KAI HUBEL ET AL: "Effective storage of granulocytes collected by centrifugation leukapheresis from..." TRANSFUSION, vol. 45, no. 12, 1 December 2005, pages 1876-1889, XP055070744, ISSN: 0041-1132.

M D PARKINS ET AL: "Overnight storage of autologous stem cell apheresis products before cryopreservation does not..." BONE MARROW TRANSPLANTATION, vol. 38, no. 9, 18 September 2006, pages 609-614, XP055144636, ISSN: 0268-3369.

WO 2005/001074 A1 (HAR-NOY MICHAEL) 6 January 2005.




US2003/0175272 A1 (MEDCELL BIOLOGICS, INC.) 18 September 2003.

M.R. DANIEL, ET AL. "Factors influencing the survival of cell monolayers during..." Br. J. exp. Path. (1976) 57, 137, pages 137-147.

EP 1792979 A1 (STIFTUNG CAESAR CENTER OF ADVANCED EUROPEANS) 06 June 2007.

US 7282198 B2 (THE UNIVERSITY OF ARKANSAN FOR MEDICAL SCIENCES) 16 October 2007.

No. of Claims: 16








[22] Date Filed: 6 December 2013

[54] Title: SIGNALING SYNTAX ELEMENTS FOR TRANSFORM COEFFICIENTS FOR SUB-SETS OF A LEAF-LEVEL CODING UNIT

[71] Proprietors(s): QUALCOMM INCORPORATED [US]

[72] Inventor(s): KARCZEWICZ, Marta[US]: WANG, Xianglin[US]: GUO, Liwei[CN]

[73] Assignee(s): QUALCOMM INCORPORATED [US]

[74] Attorney / Agent: ROMULO MABANTA BUENAVENTURA SAYOC AND DELOS ANGELES

[30] Priority Data: 13/413,475 06/03/2012 US; 61/503,541 30/06/2011 US and 61/552,341 27/10/2011 US

[51] International Class 8: H04N 7/26; H04N 7/50

[57] Abstract:

This disclosure describes techniques for coding transform coefficients for a block of video data. According to these techniques, a video encoder divides a leaf-level unit of video data into a plurality of transform coefficient sub-sets. The video encoder generates, for a sub-set of the plurality of transform coefficient sub-sets, a syntax element that indicates whether or not the sub-set includes any non-zero coefficients. In some examples, the video encoder may selectively determine whether to generate the syntax element for each sub-set. A decoder may read an entropy encoded bit stream that includes the syntax element, and determine whether to decode the sub-set based on the syntax element.







WO 2010/014759 A2 / QUALCOMM INC., et al. / 04 FEBRUARY 2010

US 2006/0104361 A1 / SUZUKI, Koichi / 18 MAY 2006

No. of Claims: 37









[54] Title: PRODUCTION METHOD FOR POLYAMIDE

[71] Proprietors(s): MITSUBISHI GAS CHEMICAL COMPANY, INC. [JP]

[72] Inventor(s): TOCHIHARA, Tatsuya[JP]: SHINOHARA, Katsumi[JP]

[73] Assignee(s): MITSUBISHI GAS CHEMICAL COMPANY, INC. [JP]

[74] Attorney / Agent: ROMULO MABANTA BUENAVENTURA SAYOC & DELOS ANGELES

[30] Priority Data: 2012-041523 28/02/2012 JP

[51] International Class 8: B01F 7/00; B01F 7/16; B01J 19/00; B01J 19/18; C08G 69/26; C08G 69/28; C08L 77/06

[57] Abstract:

The present invention is directed to a process for producing a polyamide, which process includes directly melt-polymerizing a diamine component including 70 mol % or more of p-xylylenediamine and a dicarboxylic acid component including 70 mol % or more of a C6 to C18 aliphatic dicarboxylic acid, in the absence of solvent in a batch-type reactor equipped with a stirring blade, the process including: (1) reacting the diamine component with the dicarboxylic acid component under a pressure condition of 0.2 to 0.5 MPa (Abs); (2) maintaining a vapor phase section of a reaction tank of the reactor at 200.degree. C. or higher during reaction; (3) stirring the contents of the reaction tank, from the start of adding the diamine component until after completion of the addition and before the start of pressure falling, such that the stirring-related Froude number represented by a specific formula is adjusted to 0.0002 to 0.15; and (4) employing a stirring blade having no structural body in the horizontal direction or having a structural body in the horizontal direction, which body does not come into contact with the interface between the reaction mixture and the vapor phase section during stirring. In the polyamide production process, deposition of solid matter in the reaction tank vapor section and in a vapor pipe is suppressed, and incorporation into the product of unmelted solid matter originating from the deposits is reduced.




WO 2011/065347A1 (Mitsubishi Gas Chemical Co., Inc.), 03 Jun 2011

JP 2010-007055A (Mitsubishi Gas Chemical Co., Inc.), 14 January 2010

JP 2010-007056A (Mitsubishi Gas Chemical Co., Inc.), 14 January 2010




JP 04-102631 U (Hitachi, Ltd.), 04 September 1992

No. of Claims: 12









[54] Title: NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUTED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN KINASES

[71] Proprietors(s): RHIZEN PHARMACEUTICALS SA [CH]

[72] Inventor(s): VAKKALANKA, Swaroop Kumar Venkata Satya[CH]: NAGARATHNAM, Dhanapalan[CH]: VISWANADHA, Srikant[IN]: MUTHUPPALANIAPPAN, Meyyappan[IN]: BABU, Govindarajulu[IN]: BHAVAR, Prashant K[IN]

[73] Assignee(s): RHIZEN PHARMACEUTICALS SA [CH]

[74] Attorney / Agent: ORTEGA, BACORRO, ODULIO, CALMA & CARBONELL

[30] Priority Data: 1262/CHE/2012 30/03/2012 IN

[51] International Class 8: A61K 31/437; A61P 1/16; A61P 13/12; A61P 29/00; A61P 35/00; A61P 35/02; A61P 37/02; A61P 43/00; C07D 471/04

[57] Abstract:

The present invention provides compounds useful as C-met protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of C-met kinase mediated diseases or disorders with them.




WO 2011/145035 A1 (INDIAN INCOZEN THERAPEUTICS PVT. LTD.); 24 November 2011

No. of Claims: 103









[54] Title: METHODS FOR IDENTIFYING IMMUNOBINDERS OF CELL-SURFACE ANTIGENS

[71] Proprietors(s): ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC [CH]

[72] Inventor(s): HULMANN-COTTIER, Valérie[CH]: URECH, David[CH]

[73] Assignee(s): ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC [CH]

[74] Attorney / Agent: SAPALO VELEZ BUNDANG & BULILAN LAW OFFICES

[30] Priority Data: 832/09 02/06/2009 CH; PCT/CH2009/000222 25/06/2009 CH; 61/155,041 24/02/2009 US and 61/155,105 24/02/2009 US

[51] International Class 8: C07K 16/28; C12N 15/13; C12N 5/0781; G01N 33/537

[57] Abstract: The invention provides methods for identifying immunobinders, such as scFv antibodies, capable of specifically binding to cell surface antigens, and compositions identified according to said methods.




US 2007/134249 A1 (DENNEY, Dan, et al.) 14 June 2007

ERDILE, L. F., et al.: "Whole cell ELISAfor detection..." Journal of Immunological Methods, vol. 258, no. 1-2, December 1, 2001, pages 47-53

SMITH, D., et al.: "Optimization of cellular ELISAfor aasay..." BIOTECHNIQUES, May 1997, vol. 22, no. 5, May 1997, pages 952-957.

No. of Claims: 18









[54] Title: PLANT REGULATORY ELEMENTS AND USES THEREOF

[71] Proprietors(s): MONSANTO TECHNOLOGY LLC [US]

[72] Inventor(s): FLASINSKI, Stanislaw[US]: DIETRICH, Charles, R[US]

[73] Assignee(s): MONSANTO TECHNOLOGY LLC [US]

[74] Attorney / Agent: SYCIP, SALAZAR, HERNANDEZ AND GATMAITAN

[30] Priority Data: 61/042,957 07/04/2008 US

[51] International Class 8: A01H 5/00; C12N 15/82

[57] Abstract:

The present invention provides novel regulatory elements for use in plants. The present invention also provides DNA constructs containing these novel regulatory elements; transgenic cells, plants, and seeds containing these novel regulatory elements; and methods for preparing and using the same.




US 2007130645 A1 (WU WEI, et al.) 07 JUNE 2007

WO 2005063998 A (PIONEER HI BREED INT., et al.) 14 JULY 2005

WO 2005063997 A (PIONEER HI BREED INT., et al.) 14 JULY 2005

No. of Claims: 10









[54] Title: PLANT REGULATORY ELEMENTS AND USES THEREOF

[71] Proprietors(s): MONSANTO TECHNOLOGY LLC [US]

[72] Inventor(s): FLASINSKI, Stanislaw[US]: DIETRICH, Charles, R[US]

[73] Assignee(s): MONSANTO TECHNOLOGY LLC [US]


[30] Priority Data: 61/042,957 07/04/2008 US

[51] International Class 8: A01H 5/00; C12N 15/82

[57] Abstract:

The present invention provides novel regulatory elements for use in plants. The present invention also provides DNA constructs containing these novel regulatory elements; transgenic cells, plants, and seeds containing these novel regulatory elements; and methods for preparing and using the same.




US 2007130645 A1 (WU WEI, et al.) 07 JUNE 2007

WO 2005063997 A (PIONEER HI BRED INT., et al.) 14 JULY 2005

WO2005063998 A (PIONEER HI BRED INT., et al.) 14 JULY 2005

No. of Claims: 10









[54] Title: MAGNETIC CODING SYSTEM WITH DEPOSIT OF MAGNETIC AREAS PRODUCED BY AT LEAST TWO MAGNETIC INK TYPES WITH DIFFERENT COERCITIVE FIELDS, DEPOSITED IN AN AT LEAST PARTIAL OVERLAY

[71] Proprietors(s): FEDRIGONI S.P.A. [IT]

[72] Inventor(s): LAZZERINI, Maurizio[IT]: MESSA, Gianluca[IT]

[73] Assignee(s): FEDRIGONI S.P.A. [IT]

[74] Attorney / Agent: VILLARAZA & ANGANGCO

[30] Priority Data: TO2010A000568 01/07/2010 IT

[51] International Class 8: G06K 19/06; G06K 19/12

[57] Abstract:

The present invention relates to a security element, particularly for banknotes, security cards, passports, identity cards and the like, comprising at least one magnetic area formed of at least a first and a second magnetic material having at least one different magnetic property. The second magnetic material partially covers the first magnetic material. The first magnetic material is exposed at least at two sides of the second magnetic material such that both in a first extension direction of the security element and in a second extension direction perpendicular to the first extension direction there is a change from the first magnetic material to the second magnetic material. Further, a method for reading a security element according to the invention, a system for reading a security element according to the invention, and a method for manufacturing a security element according the invention are described.




WO 2004091930 A1 HEIM, Manfred 28 October 2004

WO 2009090676 A1 LAZZERINI, Maurizio 23 July 2009

US 20090008922 A1 SCHUTZMANN et al. 08 January 2009

No. of Claims: 12









[54] Title: METHOD FOR USING A BACILLUS SUBTILIS STRAIN TO ENHANCE ANIMAL HEALTH

[71] Proprietors(s): BAYER CROPSCIENCE LP [US]

[72] Inventor(s): SCHMIDT, Joseph, Earl[US]: JIMENEZ, Desmond, Rito[US]

[73] Assignee(s): BAYER CROPSCIENCE LP [US]


[30] Priority Data: 61/192,436 17/09/2008 US

[51] International Class 8: A23K 1/00

[57] Abstract: The present invention relates to a method for enhancing the health of an animal comprising administering to the animal a composition comprising Bacillus subtilis QST 713 or a mutant thereof.




US 20030147923 A1 (KLAVINISKIS, et al.) 07 August 2003

MARRONE, P. G.:

US 6015553 A (GERMIDA, et al.) 18 January 2000

US 20030194424 A1 (LIS, et al.) 16 October 2003

US 20050031601 A1 (WYNNE, et al.) 10 February 2005

US 20040101525 A1 (LIN, et al.) 27 May 2004

No. of Claims: 15








[22] Date Filed: 24 August 2015

[54] Title: LOW PROFILE SCOOP

[71] Proprietors(s): N.V. NUTRICIA [NL]

[72] Inventor(s): CRUSIUS, Sjors Floris[NL]: BUNCE, Martin [GB]

[73] Assignee(s): N.V. NUTRICIA [NL]

[74] Attorney / Agent: CASTRO DE CLARO AND REYES LAW OFFICES

[30] Priority Data: PCT/NL2013/050114 22/02/2013 NL

[51] International Class 8: B65D 51/24; G01F 19/00

[57] Abstract:

A low profile scoop for dosing of powdered infant formula has a handle portion (41) and a bowl (51) with an open mouth and a closed underside. The bowl has a width (w) that is relatively smaller than both its length (I) and its depth (d), allowing it to be placed on its side in areas of relatively low head space. The scoop may be used in package for powdered infant nutrition comprising a tub defining a product containing space and a lid having limited head space.




DE 3542504 A1 Miele & Cie June 4, 1987

WO 2012/087619 A1 Abbott Lab June 28, 2012

US 5137316 A Foo Douglas August 11, 1992

No. of Claims: 19









[54] Title: METHODS AND SYSTEMS FOR FREQUENCY MULTIPLEXED COMMUNICATIONS IN DENSE WIRELESS ENVIRONMENTS

[71] Proprietors(s): QUALCOMM INCORPORATED [US]

[72] Inventor(s): MERLIN, Simone[US]: BARRIAC, Gwendolyn Denise[US]: SAMPATH, Hemanth [US]: VERMANI, Sameer[US]: TIAN, Bin[US]: ZHOU, Yan[US]: TANDRA, Rahul[US]

[73] Assignee(s): QUALCOMM INCORPORATED [US]


[30] Priority Data: 14/265,255 29/04/2014 US; 61/819,096 03/05/2013 US and 61/846,579 15/07/2013 US

[51] International Class 8: H04B 7/26; H04L 5/00

[57] Abstract:

Systems, methods, and devices for high-efficiency wireless frequency division multiplexing are provided. A method includes exchanging, at an access point, at least one frame reserving a wireless medium with at least one of a first and second wireless device. The method further includes receiving a first communication on a first set of wireless frequencies from the first wireless device. The method further includes receiving a second communication, at least partially concurrent with the first communication, on a second set of wireless frequencies from the second wireless device. The method further includes transmitting at least one acknowledgment of the first and second communication. The first set and the second set are mutually exclusive subsets of a set of wireless frequencies available for use by both the first and second wireless device.







US 2005/0138199 A1 (LI et al.) 23 June 2005 (23.06.2005)

EP 1,592,178 A2 (SHARP KABUSHIKI KAISHA) 02 November 2005 (02.11.2005)

WO 2010/111408 A1 (QUALCOMM INCORPORATED) 30 September 2010 (30.09.2010)

No. of Claims: 48









[54] Title: DPA-ENRICHED COMPOSITIONS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN FREE ACID FORM

[71] Proprietors(s): CHRYSALIS PHARMA AG [CH] and OMTHERA PHARMACEUTICALS, INC. [US]

[72] Inventor(s): MAINES, Timothy, J[US]: MACHIELSE, Bernardus N M[US]: MEHTA, Bharat M[US]: WISLER, Gerald[US]: DAVIDSON, Michael[US]: WOOD, Peter Ralph[GB]

[73] Assignee(s): CHRYSALIS PHARMA AG [CH] and OMTHERA PHARMACEUTICALS, INC. [US]

[74] Attorney / Agent: ORBOS, CABUSORA & TAGUIAM

[30] Priority Data: 61/583,796 06/01/2012 US; 61/664,047 25/06/2012 US; 61/669,940 10/07/2012 US; 61/680,622 07/08/2012 US; 61/710,517 05/10/2012 US and 61/713,388 12/10/2012 US

[51] International Class 8: A61K 31/19; A61P 9/00

[57] Abstract:

DPA-enriched pharmaceutical compositions of polyunsaturated fatty acids in free acid form, therapeutic methods for their use, and processes for refining the compositions from fish oil are presented. Also provided are methods of treating hypertriglyceridemia (200 mg/dL - 500 mg/dL) by adjunctive administration of a statin and the pharmaceutical compositions described herein. Further treatment methods include, inter alia, treatments to increase plasma EPA:AA ratios, treatments to decrease ApoCIII levels, and treatments to reduce or prevent resistance to platelet aggregation inhibitors.







US 5,502,077 A 26 March 1996 (26.03.1996)

US 2011/0034555 A1 10 February 2011 (10.02.2011)

US 2011/0097394 A1 28 April 2011 (28.04.2011)

No. of Claims: 38









[54] Title: ADVERTISING SYSTEM AND METHOD USING IN-APP ADVERTISEMENT MODULE

[71] Proprietors(s): BUZZVIL CO., LTD. [KR]

[72] Inventor(s): LEE, Young Ho[KR]: LEE, Gwan Woo[KR]

[73] Assignee(s): BUZZVIL CO., LTD. [KR]

[74] Attorney / Agent: MANUEL C. CASES, JR. & ASSOCIATES

[30] Priority Data: 10-2013-0048796 30/04/2013 KR

[51] International Class 8: G06Q 30/02

[57] Abstract:

The present invention relates to an advertising system and a method using an in-App advertisement module, which is capable of displaying an advertisement on a locked screen by through an advertisement module which is inserted in one or more application and is installed in parallel to the applications and distributing saved rewards to the applications according to a user input through the lock screen on which the advertisement is displayed, thereby allowing the saved rewards to be used as points.




KR 1020130000318 A Hwang Doo Ho January 2, 2013

US 2013/0067035 A1 Amanat Omar March 14, 2013

US 8417570 B2 Thiekle Patrick April 9, 2013

No. of Claims: 21









[54] Title: IMPROVEMENTS RELATING TO A BLISTER PACK AND ITS PRODUCTION

[71] Proprietors(s): MANREX PTY LTD [AU]

[72] Inventor(s): STEVENS, Gerard[AU]

[73] Assignee(s): MANREX PTY LTD [AU]

[74] Attorney / Agent: FEDERIS AND ASSOCIATES LAW OFFICES

[30] Priority Data: 2013902426 28/06/2013 AU

[51] International Class 8: A61J 1/03; B65D 75/36

[57] Abstract:

A protected blister package (50) assembled by a pharmacist for a patient has the correctness of its assembly confirmed by checking the correct correlation of three binary codes (17) respectively appearing on three components of the package. The codes are intended to provide information relating to the identity of the patient and the nature and quantity of prescribed medication doses in the blisters of the package. The first component comprises a blister sheet (58) loaded with the prescribed medication doses; the second component comprises a backing sheet (57) sealing the medication doses in the cavities of the package blisters; and the third component comprises a protective card (51) having fold lines (52,53 and 54) enabling it to be folded around the blister package (50) after it has been attached to the card. Prior to assembly of the blister package two of the binary codes (17) are printed on the backing sheet (57) and the third binary code is printed on the card. The three codes are printed at the same time to ensure that they are identical. During assembly of the package a portion of the backing sheet bearing one of its two codes is transferred to a predetermined position on the blister sheet. Correct horizontal positioning of the blister package (50) in the card achieved by lining up the left hand edge of the package with the fold line (52) and correct vertical positioning of the package is achieved by lining up the set of blocks (56) on the package with the set of blocks (55) on the protective card (51) After assembly of the protected blister package the three binary codes (17) are scanned to check that they are identical. If identity of the three codes is confirmed the package has been correctly assembled.







CA 2498920 A1 Apothecary Products Inc. April 21, 2006

WO 2011/041543 A1 meadwestvaco Corp. April 7, 2011

US 7983995 B2 Murphy, et. al. June 19, 2011

No. of Claims: 6








[22] Date Filed: 6 January 2016

[54] Title: BICYCLE SADDLE

[71] Proprietors(s): SELLE SMP S.A.S DI MAURIZIO SCHIAVON [IT]

[72] Inventor(s): SCHIAVON, Franco[IT]: SCHIAVON, Maurizio[IT]

[73] Assignee(s): SELLE SMP S.A.S DI MAURIZIO SCHIAVON [IT]


[30] Priority Data: VI2013A000182 18/07/2013 IT

[51] International Class 8: B62J 1/00

[57] Abstract:

The finding concerns a bicycle saddle, which is of a type similar to the saddle described in documents EP 1 590 229 and EP 1 781 528, of the type that has two identical portions (30, 31) arranged symmetrically with respect to its longitudinal axis; at said longitudinal axis there is, in particular, a channel (15) that is open from top to bottom. Such a saddle, at the front, when seen from the side, takes up a bird's beak configuration. Said saddle is characterized in that the two portions (30, 31), at their rear ends, until they reach the extensions (9, 10) that face the central channel, have substantially flat areas (1, 2) (on which the gluteal muscles of the user are intended to sit during the use of the saddle) which are substantially parallel to the ground on which the wheels of the bicycle rest.







WO 2012107215 A1 — SELLE SMP SAS DI MAURIZIO SCHIAVON et al. — 16 August 2012

US 2006152047 A1 — RIONDATO, Francesco — 13 July 2006

No. of Claims: 5

1 INVENTIONS · 2018. 7. 5. · There is disclosed an information processing device that displays a link related to one peripheral device on a device screen. The information processing

Documents